Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK8 | P49336 | 4/20 | 0.48 |
| ▸ | KDR | P35968 | 5/20 | 0.46 |
| ▸ | RAF1 | P04049 | 6/20 | 0.44 |
| ▸ | BRAF | P15056 | 5/20 | 0.43 |
| ▸ | KIT | P10721 | 2/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.43 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.43 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.43 |
| ▸ | FLT3 | P36888 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL282579 | 0.87 | CDK8 (0.61) | CDK8KDRRAF1BRAFKIT | |
| SCHEMBL282624 | 0.78 | CDK8 (0.61) | CDK8KDRRAF1BRAFKIT | |
| SCHEMBL281698 | 0.77 | RAF1 (0.50) | CDK8KDRRAF1BRAFKIT | |
| SCHEMBL282705 | 0.75 | KDR (0.61) | KDRRAF1BRAFKITPDGFRB | |
| SCHEMBL281926 | 0.74 | CSF1R (0.58) | KDRRAF1BRAFKITPDGFRB | |
| SCHEMBL10073789 | 0.74 | CSF1R (0.57) | CDK8KDRBRAFPDGFRAFLT3 | |
| SCHEMBL717713 | 0.73 | ICAM1 (0.51) | CDK8 | |
| SCHEMBL282580 | 0.67 | KDR (0.66) | CDK8KDRRAF1BRAFKIT | |
| SCHEMBL282422 | 0.67 | ICAM1 (0.50) | CDK8 | |
| SCHEMBL21357120 | 0.67 | CDK8 (0.70) | CDK8KDRRAF1BRAFKIT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2428506-A1 | HETEROCYCLIC SUBSTITUTED ACARDITE DERIVATES AND USE THEREOF | Jiangsu Provincial Institute Of Materia Medica Co. (CN) | 2012-03-14 | — | — | EP | claimed |